Literature DB >> 10523567

Comparison of the OptiMAL test with PCR for diagnosis of malaria in immigrants.

J Iqbal1, A Sher, P R Hira, R Al-Owaish.   

Abstract

The OptiMAL test (Flow Inc., Portland, Oreg.), which detects a malaria parasite lactate dehydrogenase (pLDH) antigen, has not been evaluated for its sensitivity in the diagnosis of malaria infection in various epidemiological settings. Using microscopy and a PCR as reference standards, we performed a comparison of these assays with the OptiMAL test for the detection of Plasmodium falciparum and Plasmodium vivax infection in 550 immigrants who had come from areas where malaria is endemic to reside in Kuwait, where malaria is not endemic. As determined by microscopy, 125 (23%) patients had malaria, and of these, 84 (67%) were infected with P. vivax and 36 were infected with P. falciparum; in 5 cases the parasite species could not be determined due to a paucity of the parasites. The PCR detected malaria infection in 145 (26%) patients; 102 (70%) of the patients had P. vivax infection and 43 had P. falciparum infection. Of the five cases undetermined by microscopy, the PCR detected P. falciparum infection in two cases, P. vivax infection in two cases, and mixed (P. falciparum plus P. vivax) infection in one case. Correspondingly, the OptiMAL test detected malaria infection in 95 patients (17%); of these, 70 (74%) had P. vivax infection and 25 were infected with P. falciparum. In this study, 61 (49%) of the 125 malaria cases, as confirmed by microscopy, had a degree of parasitemia of <100 parasites per microl, and 23 (18%) of the cases had a degree of <50 parasites per microl. Our results show that the sensitivity of the OptiMAL test is high (97%) at a high level of parasitemia (>100 parasites/microl) but drops to 59% when the level is <100 parasites/microl and to 39% when it is <50 parasites/microl. In addition, the OptiMAL test failed to identify four patients whose blood smears contained P. falciparum gametocytes only. We conclude that the sensitivity and specificity of the OptiMAL test are comparable to those of microscopy in detecting malaria infection at a parasitemia level of >100 parasites/microl; however, the test failed to identify more than half of the patients with a parasitemia level of <50 parasites/microl. Thus, the OptiMAL test should be used with great caution, and it should not replace conventional microscopy in the diagnosis of malaria infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523567      PMCID: PMC85714     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  18 in total

1.  Evaluation of two tests based on the detection of histidine rich protein 2 for the diagnosis of imported Plasmodium falciparum malaria.

Authors:  J Van den Ende; T Vervoort; A Van Gompel; L Lynen
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 May-Jun       Impact factor: 2.184

2.  A malaria vaccine based on a sporozoite antigen.

Authors:  R S Nussenzweig; F Zavala
Journal:  N Engl J Med       Date:  1997-01-09       Impact factor: 91.245

3.  Evaluation of a non-isotopic polymerase chain reaction-based assay to detect and predict treatment failure of Plasmodium vivax malaria in travellers.

Authors:  A Humar; M A Harrington; K C Kain
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Jul-Aug       Impact factor: 2.184

4.  Comparative evaluation of four techniques for the diagnosis of Plasmodium falciparum infections.

Authors:  M H Craig; B L Sharp
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 May-Jun       Impact factor: 2.184

Review 5.  Primaquine resistance in Plasmodium vivax.

Authors:  W E Collins; G M Jeffery
Journal:  Am J Trop Med Hyg       Date:  1996-09       Impact factor: 2.345

6.  Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections.

Authors:  G Snounou; S Viriyakosol; W Jarra; S Thaithong; K N Brown
Journal:  Mol Biochem Parasitol       Date:  1993-04       Impact factor: 1.759

7.  Imported Plasmodium falciparum malaria in American travelers to Africa. Implications for prevention strategies.

Authors:  E M Lackritz; H O Lobel; B J Howell; P Bloland; C C Campbell
Journal:  JAMA       Date:  1991-01-16       Impact factor: 56.272

8.  Comparison of the ParaSight-F test and the ICT Malaria Pf test with the polymerase chain reaction for the diagnosis of Plasmodium falciparum malaria in travellers.

Authors:  P Pieroni; C D Mills; C Ohrt; M A Harrington; K C Kain
Journal:  Trans R Soc Trop Med Hyg       Date:  1998 Mar-Apr       Impact factor: 2.184

9.  Diagnosis of malaria by detection of Plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen-capture assay.

Authors:  C Beadle; G W Long; W R Weiss; P D McElroy; S M Maret; A J Oloo; S L Hoffman
Journal:  Lancet       Date:  1994-03-05       Impact factor: 79.321

10.  Screening donor blood for malaria by polymerase chain reaction.

Authors:  T T Vu; V B Tran; N T Phan; T T Le; V H Luong; E O'Brien; G E Morris
Journal:  Trans R Soc Trop Med Hyg       Date:  1995 Jan-Feb       Impact factor: 2.184

View more
  17 in total

1.  Imported visceral leishmaniasis: diagnostic dilemmas and comparative analysis of three assays.

Authors:  Jamshaid Iqbal; Parsotam R Hira; Grover Saroj; Reeni Philip; Faiza Al-Ali; Patrick J Madda; Ali Sher
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

2.  Submicroscopic Plasmodium falciparum infections before and after sulfadoxine-pyrimethamine and artesunate association treatment in Dienga, Southeastern Gabon.

Authors:  Fousseyni S Touré; Jérôme Mezui-Me-Ndong; Odile Ouwe-Missi-Oukem-Boyer; Benjamin Ollomo; Dominique Mazier; Sylvie Bisser
Journal:  Clin Med Res       Date:  2006-09

3.  Evaluation of the ICT malaria P.f/P.v and the OptiMal rapid diagnostic tests for malaria in febrile returned travellers.

Authors:  E Geoffrey Playford; John Walker
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Malaria rapid diagnostic devices: performance characteristics of the ParaSight F device determined in a multisite field study.

Authors:  J R Forney; A J Magill; C Wongsrichanalai; J Sirichaisinthop; C T Bautista; D G Heppner; R S Miller; C F Ockenhouse; A Gubanov; R Shafer; C C DeWitt; H A Quino-Ascurra; K E Kester; K C Kain; D S Walsh; W R Ballou; R A Gasser
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

Review 5.  Rapid diagnostic tests for malaria parasites.

Authors:  Anthony Moody
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

6.  Comparison of two commercial assays with expert microscopy for confirmation of symptomatically diagnosed malaria.

Authors:  Jamshaid Iqbal; Nabila Khalid; Parsotam R Hira
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

7.  Rapid diagnosis of vivax malaria by the SD Bioline Malaria Antigen test when thrombocytopenia is present.

Authors:  Sei Won Lee; Kyeongman Jeon; Byung Ryul Jeon; Inho Park
Journal:  J Clin Microbiol       Date:  2007-12-26       Impact factor: 5.948

8.  Development of a real-time PCR assay for detection of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale for routine clinical diagnosis.

Authors:  F Perandin; N Manca; A Calderaro; G Piccolo; L Galati; L Ricci; M C Medici; M C Arcangeletti; G Snounou; G Dettori; C Chezzi
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

9.  Comparison of blood smear, antigen detection, and nested-PCR methods for screening refugees from regions where malaria is endemic after a malaria outbreak in Quebec, Canada.

Authors:  Momar Ndao; Etienne Bandyayera; Evelyne Kokoskin; Theresa W Gyorkos; J Dick MacLean; Brian J Ward
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

10.  Multicenter study to evaluate the OptiMAL test for rapid diagnosis of malaria in U.S. hospitals.

Authors:  Carol J Palmer; J Alfredo Bonilla; David A Bruckner; Elizabeth D Barnett; Nancy S Miller; M A Haseeb; Joseph R Masci; William M Stauffer
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.